Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 19

Results For "CCO"

1761 News Found

Sun Pharma’s ‘Heart ke Liye 8’ campaign clocks 24.1 million views online
Healthcare | April 21, 2026

Sun Pharma’s ‘Heart ke Liye 8’ campaign clocks 24.1 million views online

This includes 14.3 million views on YouTube and 9.8 million views on Meta platforms to amplify preventive heart health message


Loopworm’s silkworm-based ingredients found carbon negative in PwC-backed study
Biotech | April 20, 2026

Loopworm’s silkworm-based ingredients found carbon negative in PwC-backed study

The study was conducted by PwC India in line with ISO 14040 and ISO 14044 protocols


Apollo Hospitals appoints Dr Harit Kumar Chaturvedi as CEO
People | April 20, 2026

Apollo Hospitals appoints Dr Harit Kumar Chaturvedi as CEO

Move to accelerate cancer care expansion across India


Aurobindo Pharma wins key FDA nod for $138M US cough drug market entry
Drug Approval | April 20, 2026

Aurobindo Pharma wins key FDA nod for $138M US cough drug market entry

The drug is designed to provide temporary relief from cough caused by throat and bronchial irritation


GE HealthCare expands DeepHealth AI partnership to supercharge breast cancer detection
Medical Device | April 20, 2026

GE HealthCare expands DeepHealth AI partnership to supercharge breast cancer detection

The move aims to accelerate the development, commercialization, and global rollout of advanced AI-powered mammography tools


Philips wins FDA nod for AI-powered spectral CT system Verida
Medical Device | April 20, 2026

Philips wins FDA nod for AI-powered spectral CT system Verida

At the core of Verida is Spectral Precise Image technology paired with a third-generation Nano-panel Precise dual-layer detector and an AI-based deep learning reconstruction engine


Cipla receives two observations following USFDA inspection at Goa facility
Drug Approval | April 18, 2026

Cipla receives two observations following USFDA inspection at Goa facility

The company stated that it will work closely with the regulator to address the observations within the stipulated timeframe